Feasibility study of combined detection of five urinary modified nucleosides and plasma EBV-DNA in the diagnosis of nasopharyngeal carcinoma
MAO Fei-xia1,2 ZHANG Yi-min1,2 ZHANG Jian-ying1,2▲
1.Department of Clinical Laboratory,Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital),Zhejiang Province,Hangzhou 310022,China;
2.Institute of Basic Medicine and Cancer,Chinese Academy of Sciences,Zhejiang Province,Hangzhou 310022,China
Abstract:Objective To explore the feasibility of combined detection of five urinary modified nucleosides and plasma EBV-DNA in the diagnosis of nasopharyngeal carcinoma.Methods A total of 56 patients with nasopharyngeal carcinoma treated in Zhejiang Cancer Hospital from January to June 2020 were selected as the nasopharyngeal carcinoma group and 32 healthy subjects during the same period were selected as the healthy control group.Liquid chromatography-tandem mass spectrometry was employed to measure the concentrations of modified nucleosides pseudouridine(Pseu),2-O-methylguanosine(m2G),1-methyladenosine(m1A),6-methyladenosine(m6A)and 1-methylguanosine(m1G)in urine samples.The levels of Pseu,m2G,m1A,m6A and m1G in urine samples of the two groups were compared.Fluorescent quantitative polymerase chain reaction was employed to measure the level of the plasma EBV-DNA in peripheral blood samples collected from all the subjects.Receiver operating characteristic(ROC)curve was made to evaluate the diagnostic value of single detection and combined detection of urinary nucleosides and plasma EBV-DNA.Results The levels of Pseu,m2G,m1A and m1G in the nasopharyngeal carcinoma group were higher than those in the healthy control group,the differences were statistically significant(P<0.05).The level of the plasma EBV-DNA in the nasopharyngeal carcinoma group was higher than that in the healthy control group,the difference was statistically significant(P<0.05).The area under the curve(AUC)of the combined detection was higher than that of m2G,m1A,Pseu,m1G and EBV-DNA in individuals,the differences were statistically significant(P<0.05).In the nasopharyngeal carcinoma patients,the Pseu concentration was positively correlated with clinical stage and lymph node metastasis(r=0.474,0.406,P<0.01).Conclusion The urinary modified nucleosides Pseu,m2G,m1A and m1G may be small molecular markers for the diagnosis of nasopharyngeal carcinoma.The combined detection of the four urinary nucleosides with plasma EBV-DNA may help to improve the diagnostic efficiency of nasopharyngeal carcinoma.
茅飞霞; 张毅敏;张剑英. 5种尿液修饰核苷联合血浆EBV-DNA定量检测在鼻咽癌诊断中的可行性研究[J]. 中国当代医药, 2021, 28(14): 8-12.
MAO Fei-xia; ZHANG Yi-min; ZHANG Jian-ying. Feasibility study of combined detection of five urinary modified nucleosides and plasma EBV-DNA in the diagnosis of nasopharyngeal carcinoma. 中国当代医药, 2021, 28(14): 8-12.
Lo YM,Chan LY,Lo KW,et al.Quantitative analysis of cell-free EpsteinBarr virus DNA in plasm of patients with nasopharyngeal carcinoma[J].Cancer Res,1999,59(6):1188-1191.
[6]
Zhao F,Liu X,Chen X,et al.Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma[J].Oncol Lett,2015,10(5):2888-2894.
Alfieri S,Iacovelli NA,Marceglia S,et al.Circulating pretreatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area[J].Oncotarget,2017,8(29):47 780-47 789.
Jiang T,Lin YL,Yin HQ,et al.Correlation analysis of urine metabolites and clinical staging in patients with ovarian cancer[J].Int J Clin Exp Med,2015,8(10):18 165-18 171.
[16]
Feng B,Zheng MH,Zheng YF,et al.Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring[J].J Gastroenterol Hepatol,2005,20(12):1913-1919.
[17]
Songe-Mller L,van den Born E,Leihne V,et al.Mammalian ALKBH8 possesses tRNA methyltransferase activity required for the biogenesis of multiple wobble uridine modifications implicated in translational decoding[J].Mol Cell Biol,2010,30(7):1814-1827.